Bristol Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,300
Closed -$426K 56
2018
Q4
$426K Buy
+3,300
New +$460K 0.51% 34
2018
Q2
Sell
-24,600
Closed -$3.15M 70
2018
Q1
$3.15M Buy
24,600
+21,300
+645% +$2.88M 10.28% 2
2017
Q4
$461K Sell
3,300
-6,100
-65% -$850K 0.29% 52
2017
Q3
$1.22M Buy
9,400
+4,700
+100% +$623K 1.23% 20
2017
Q2
$622K Sell
4,700
-600
-11% -$76.5K 0.41% 21
2017
Q1
$660K Sell
5,300
-6,600
-55% -$788K 0.75% 17
2016
Q4
$1.37M Buy
+11,900
New +$1.37M 1.38% 17

Other funds holding JNJ

Bristol Advisors's JNJ Position: Q1 2019 in Review

Bristol Advisors sold out of Johnson & Johnson (JNJ) in Q1 2019, closing a stake of 3,300 shares — an estimated $426K sold.

Bristol Advisors first reported a position in JNJ in Q4 2016 and held it in 7 quarters. The position peaked at $3.15M in Q1 2018. 2,765 funds tracked by Wall St. Rank hold JNJ as of Q1 2019.

  • Bristol Advisors reported no remaining Johnson & Johnson position as of Q1 2019 after selling out during the quarter.
  • Bristol Advisors sold 3,300 Johnson & Johnson shares in Q1 2019, an estimated $426K.
  • Bristol Advisors first reported a position in Johnson & Johnson in Q4 2016 and held it in 7 quarters.
  • Bristol Advisors's Johnson & Johnson position peaked at $3.15M in Q1 2018.
  • 2,765 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2019.

Based on Bristol Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.